dc.contributor.author |
Kharlamova A. |
|
dc.contributor.author |
Petrov K. |
|
dc.contributor.author |
Zueva I. |
|
dc.contributor.author |
Nikolsky E. |
|
dc.date.accessioned |
2018-09-19T23:02:47Z |
|
dc.date.available |
2018-09-19T23:02:47Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
2313-1829 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/145931 |
|
dc.description.abstract |
The review addresses issues of etiological studies of synaptic defects underlying severe immunological disease of neuromuscular system myasthenia gravis. Current concepts on molecular mechanisms of muscle weakness accompanying this disease are considered, development of new algorithms of myasthenia gravis treatment is discussed. |
|
dc.relation.ispartofseries |
Genes and Cells |
|
dc.subject |
Autoimmune diseases |
|
dc.subject |
Myasthenia gravis |
|
dc.subject |
Synaptic transmission |
|
dc.title |
Etiopathogenesis and principles of myasthenia gravis treatment |
|
dc.type |
Review |
|
dc.relation.ispartofseries-issue |
4 |
|
dc.relation.ispartofseries-volume |
10 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
15 |
|
dc.source.id |
SCOPUS23131829-2016-10-4-SID84962217184 |
|